Academic Journals Database
Disseminating quality controlled scientific knowledge

Search Articles for "non-alcoholic steatohepatitis"

ADD TO MY LIST
 
Non Alcoholic Fatty Liver Diseases in Chronic Hepatitis C: Impact on End Treatment Virologic Response

Author(s): Mahmoud Abdel-Aziz | Azza Abdel-Aziz | Mohammed M. El-Arman
Fat: A matter of disturbance for the immune system

Author(s): Alessandro Federico, Elena D’Aiuto, Francesco Borriello, Giusi Barra, Antonietta Gerarda Gravina, Marco Romano, Raffaele De Palma
Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis

Author(s): Carmen Fierbinteanu-Braticevici, Ion Dina, Ana Petrisor, Laura Tribus, Lucian Negreanu, Catalin Carstoiu
Non-viral causes of hepatocellular carcinoma

Author(s): Wojciech Blonski, David S Kotlyar, Kimberly A Forde
Recurrent and de novo non-alcoholic steatohepatitis following orthotopic liver transplantation

Author(s): GARCIA Raquel F. Liermann | MORALES Eugenia | GARCIA Christian Evangelista | SAKSENA Sushma | HÜBSCHER Stefan G. | ELIAS Elwin
Clinical and histological features of nonalcoholic steatohepatitis in Iranian patients

Author(s): Bahrami Hossein | Daryani Nasser | Mirmomen Shahram | Kamangar Farin | Haghpanah Babak | Djalili Mehdi
REVIEW PAPERNon-alcoholic steatohepatitis (NASH)

Author(s): János Fehér | Eszter Németh | Gabriella Lengyel
The non-alcoholic fatty liver disease’s progression is associated to obesity and hepatic oxidative stress

Author(s): Rodrigo Andrés Carrasco Loza | Rodrigo Luis Castillo Peñaloza | Patricio Andrés Huerta Bustamante | Lilian Thieleman
Concepts in leptin and liver disease

Author(s): El-Badawy Reda | Al-Ghamdi Abdullah | Al-Mofleh Ibrahim
A Pilot Study of Pioglitazone for the Treatment of Non-Alcoholic Fatty Liver Disease

Author(s): Abeer Al-Gharabally | Christopher B. O'Brien | Rita C.Acosta
Hepatology – Guidelines on Parenteral Nutrition, Chapter 16

Author(s): Plauth, M. | Schuetz, T. | Working group for developing the guidelines for parenteral nutrition of The German Association for Nutritional Medicine
ELEVATED ALT AND AST IN AN ASYMPTOMATIC PERSON

Author(s): Loh Keng Yin | Kew Siang Tong
Is there any progress in the treatment of non-alcoholic fatty liver disease?

Author(s): Emmanuel A Tsochatzis | George V Papatheodoridis
Non-alcoholic steatohepatitis with normal aminotransferase values

Author(s): Hüseyin Saadettin Uslusoy, Selim Giray Nak, Macit Gülten, Zeynep Bıyıklı
Evaluating Risk Factors for Development of Non-Alcoholic Steatohepatitis in Type-II Diabetes Mellitus

Author(s): Deepak N. Amarapurkar | Nikhil D. Patel | Praful M. Kamani
Enhanced serum concentrations of transforming growth factor-beta1 in simple fatty liver: is it really benign?

Author(s): Tarantino Giovanni | Conca Paolo | Riccio Antonio | Tarantino Marianna | Di Minno Matteo | Chianese Domenico | Pasanisi Fabrizio | Contaldo Franco | Scopacasa Francesco | Capone Domenico
FATTY LIVER IN THE PATIENTS WITH HYPERLIPIDEMIA, OBESITY AND DIABETES MELLITUS

Author(s): Admir Candic | Edina Candic | Ajsa Tulumovic | Denijal Tulumovic | Slavko Nikic | Azrija Pasalic
Serum procalcitonin and CRP levels in non-alcoholic fatty liver disease: a case control study

Author(s): Oruc Nevin | Ozutemiz Omer | Yuce Gul | Akarca Ulus | Ersoz Galip | Gunsar Fulya | Batur Yucel
Losartan, an angiotensin-II type 1 receptor blocker, attenuates the liver fibrosis development of non-alcoholic steatohepatitis in the rat

Author(s): Yoshiji Hitoshi | Noguchi Ryuichi | Ikenaka Yasuhide | Namisaki Tadashi | Kitade Mitsuteru | Kaji Kosuke | Shirai Yusaku | Yoshii Junichi | Yanase Koji | Yamazaki Masaharu | Tsujimoto Tatsuhiro | Kawaratani Hideto | Akahane Takemi | Aihara Yosuke | Fukui Hiroshi
A proteomic strategy to identify novel serum biomarkers for liver cirrhosis and hepatocellular cancer in individuals with fatty liver disease

Author(s): Gray Joe | Chattopadhyay Dipankar | Beale Gary | Patman Gillian | Miele Luca | King Barry | Stewart Stephen | Hudson Mark | Day Christopher | Manas Derek | Reeves Helen
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis?

Author(s): Tarantino Giovanni | Citro Vincenzo | Conca Paolo | Riccio Antonio | Tarantino Marianna | Capone Domenico | Cirillo Michele | Lobello Roberto | Iaccarino Vittorio
Wilson’s disease masquerading as nonalcoholic steatohepatitis

Author(s): Sabina Mahmood | Nobu Inada | Akiyoshi Izumi | Miwa Kawanaka | Haruhiko Kobashi | Gotaro Yamad
A preliminary study of inflammatory markers in non-alcoholic steatohepatitis patients

Author(s): Manopriya T. Priya | Dhastagir Sultan Sheriff
Hepatoprotective effects of Spirulina maxima in patients with non-alcoholic fatty liver disease: a case series

Author(s): Ferreira-Hermosillo Aldo | Torres-Duran Patricia | Juarez-Oropeza Marco
A Bird's Eye View of Non Alcoholic Fatty Liver Disease - an Insulin Resistant State

Author(s): Manopriya T Priya | Elshaari Faraj Ali | Dhastagir S Sheriff
Toll-like receptor-2 deficiency enhances non-alcoholic steatohepatitis

Author(s): Rivera Chantal | Gaskin LaTausha | Allman Monique | Pang Jia | Brady Kristen | Adegboyega Patrick | Pruitt Kevin
Toll-Like Receptor Signaling and Liver Fibrosis

Author(s): Tomonori Aoyama | Yong-Han Paik | Ekihiro Seki
HIGH SENSITIVITY C-REACTIVE PROTEIN AS PREDICTION FACTOR OF DISEASE PROGRESSION IN PATIENTS WITH CHRONIC HEPATITIS C AND MILD LIVER STEATOSIS

Author(s): Lidija Popović-Dragonjić | Maja Jovanović | Miodrag Vrbić | Ljiljana Konstantinović | Velimir Kostić | Ivan Dragonjić
Heme oxygenase-1 prevents non-alcoholic steatohepatitis through suppressing hepatocyte apoptosis in mice

Author(s): Nan YueMin | Wang RongQi | Zhao SuXian | Han Fang | Wu Wen | Kong LingBo | Fu Na | Kong Li | Yu Jun
Predictors of non-alcoholic fatty liver disease in obese and overweight Egyptian children: Single center study

Author(s): El-Karaksy Hanaa | El-Koofy Nehal | Anwar Ghada | El-Mougy Fatma | El-Hennawy Ahmed | Fahmy Mona
Comparative nucleic acid transfection efficacy in primary hepatocytes for gene silencing and functional studies

Author(s): Park Jae-Seung | Surendran Sneha | Kamendulis Lisa | Morral Núria
An operative case of hepatic pseudolymphoma difficult to differentiate from primary hepatic marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue

Author(s): Hayashi Michihiro | Yonetani Noboru | Hirokawa Fumitoshi | Asakuma Mitsuhiro | Miyaji Katsuhiko | Takeshita Atsushi | Yamamoto Kazuhiro | Haga Hironori | Takubo Takayuki | Tanigawa Nobuhiko
Combination drug treatment in patients with non-alcoholic fatty liver disease

Author(s): Theodosios D Filippatos, Moses S Elisaf
Pro12Ala polymorphism of the peroxisome proliferator-activated receptor γ2 in patients with fatty liver diseases

Author(s): Johannes W Rey, Andrea Noetel, Aline Hardt, Ali Canbay, Hakan Alakus, Axel zur Hausen, Hans Peter Dienes, Uta Drebber, Margarete Odenthal
PTEN in liver diseases and cancer

Author(s): Marion Peyrou, Lucie Bourgoin, Michelangelo F
Non-alcoholic steatohepatitis and influence of age and gender on histopathologic findings

Author(s): Nargess Ebrahimi Daryani, Nasser Ebrahimi Daryani, Seyed Moayed Alavian, Ali Zare, Seyed-Mohammad Fereshtehnejad, Mohammad Reza Keramati, Mohammad Reza Pashaei, Peiman Habibollahi
Steatosis and steatohepatitis in postmortem material from Northwestern Greece

Author(s): Christos D Zois, Gerasimos H Baltayiannis, Anna Bekiari, Anna Goussia, Peter Karayiannis, Michalis Doukas, Demetrios Demopoulos, Antigoni Mitsellou, Theodoros Vougiouklakis, Vasiliki Mitsi, Epameinondas V Tsianos
Angiotensin-receptor blockers as therapy for mild-to-moderate hypertension-associated non-alcoholic steatohepatitis

Author(s): Eugen Florin Georgescu, Reanina Ionescu, Mihaela Niculescu, Laurentiu Mogoanta, Liliana Vancica
Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis and disease progression

Author(s): Genetic polymorphisms in non-alcoholic fatty liver disease: Clues to pathogenesis, disease progression
Olive oil consumption and non-alcoholic fatty liver disease

Author(s): Nimer Assy, Faris Nassar, Gattas Nasser, Maria Grosovski
Crosstalk between angiogenesis, cytokeratin-18, and insulin resistance in the progression of non-alcoholic steatohepatitis

Author(s): Mitsuteru Kitade, Hitoshi Yoshiji, Ryuichi Noguchi, Yasuhide Ikenaka, Kosuke Kaji, Yusaku Shirai, Masaharu Yamazaki, Masahito Uemura, Junichi Yamao, Masao Fujimoto, Akira Mitoro, Masahisa Toyohara, Masayoshi Sawai, Motoyuki Yoshida, Chie Morioka, Tatsuhiro Tsujimoto, Hideto Kawaratani, Hiroshi Fukui
Hyperferritinemia is a risk factor for steatosis in chronic liver disease

Author(s): Anna Licata, Maria Elena Nebbia, Giuseppe Cabibbo, Giovanna Lo Iacono, Francesco Barbaria, Virna Brucato, Nicola Alessi, Salvatore Porrovecchio, Vito Di Marco, Antonio Craxì, Calogero Cammà
Non-alcoholic fatty liver disease and the metabolic syndrome: An update

Author(s): R Scott Rector, John P Thyfault, Yongzhong Wei, Jamal A Ibdah
A Preliminary Application of Magnetic Resonance Spectroscopy for Quantitatively Assessing Hepatic Fat and the Efficacy of Anti-obesity Therapy

Author(s): Hyunseung Lee | Kyeong-Hoon Jeong | Myoung Gyu Park | Jongeun Kang | Kwan Soo Hong
Nonalcoholic fatty liver disease: An overview of current insights in pathogenesis, diagnosis, treatment

Author(s): Tim CMA Schreuder, Bart J Verwer, Carin MJ van Nieuwkerk, Chris JJ Mulder
Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats

Author(s): Sheng Li, Wan-Chun Wu, Chi-Yi He, Zhen Han, Dao-You Jin, Lin Wang
Non-invasive means of measuring hepatic fat content

Author(s): Sanjeev R Mehta, E Louise Thomas, Jimmy D Bell, Desmond G Johnston, Simon D Taylor-Robinson
Innate immune reactivity of the liver in rats fed a choline-deficient L-amino-acid-defined diet

Author(s): Hideto Kawaratani, Tatsuhiro Tsujimoto, Toshiyuki Kitazawa, Mitsuteru Kitade, Hitoshi Yoshiji, Masahito Uemura, Hiroshi Fukui
Prevalence of metabolic syndrome, obesity and diabetes type 2 in cryptogenic cirrhosis

Author(s): Felix I Tellez-Avila, Francisco Sanchez-Avila, Mauricio García-Saenz-de-Sicilia, Norberto C Chavez-Tapia, Ada M Franco-Guzman, Gustavo Lopez-Arce, Eduardo Cerda-Contreras, Misael Uribe
Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice

Author(s): Stanton Michaela | Chen Shu-Cheng | Jackson James | Rojas-Triana Alberto | Kinsley David | Cui Long | Fine Jay | Greenfeder Scott | Bober Loretta | Jenh Chung-Her
Mallory-Denk Bodies in chronic hepatitis

Author(s): Metin Basaranoglu | Nesrin Turhan | Abdullah Sonsuz | Gökcen Basaranoglu
Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease

Author(s): Santos V.N. dos | Leite-Mór M.M.B. | Kondo M. | Martins J.R. | Nader H. | Lanzoni V.P. | Parise E.R.
The role of leptin in non-alcoholic fatty liver disease

Author(s): Elbadawy Reda | Eleter Eman | Helmy Ahmed | Al Ghamdi Abdalla | Al-Mofleh Ibrahim | Al Faleh Faleh | Al Freihi Hussain | Al-Amri Saleh
Microvessel Density and Clinicopathologic Characteristics in Hepatocellular Carcinoma With and Without Cirrhosis

Author(s): Ivan Chebib | Meer Taher Shabani-Rad | Michelle S. Chow | James Zhang | Zu-hua Gao
AFP, PIVKAII, GP3, SCCA-1 and follisatin as surveillance biomarkers for hepatocellular cancer in non-alcoholic and alcoholic fatty liver disease

Author(s): Beale Gary | Chattopadhyay Dipankar | Gray Joe | Stewart Stephen | Hudson Mark | Day Christopher | Trerotoli Paolo | Giannelli Gianluigi | Manas Derek | Reeves Helen
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease

Author(s): Giovanni Tarantino | Francesco Scopacasa | Annamaria Colao | Domenico Capone | Marianna Tarantino | Ernesto Grimaldi | Silvia Savastano
Role of cytokines and chemokines in non-alcoholic fatty liver disease

Author(s): Vincent Braunersreuther | Giorgio Luciano Viviani | François Mach | Fabrizio Montecucco
Markedly lower follow-up rate after liver biopsy in patients with non-alcoholic fatty liver diseases than those with viral hepatitis in Japan

Author(s): Toyoda Hidenori | Kumada Takashi | Kiriyama Seiki | Tanikawa Makoto | Hisanaga Yasuhiro | Kanamori Akira | Tada Toshifumi
Physical activity and nutrition attitudes in obese Hispanic children with non-alcoholic steatohepatitis

Author(s): Lana N Hattar | Theresa A Wilson | Leanel A Tabotabo | E O’Brian Smith | Stephanie H Abrams
Hepatobiliary dysfunction in patients with inflammatory bowel disease

Author(s): E.B.N Daryani | A.H. Jafari Sepehr | M. Tajik Rostami | M. Bashasti
Role of ezetimibe in non-alcoholic fatty liver disease

Author(s): Theodosios D Filippatos | Moses S Elisaf
Management of Non Alcoholic Fatty Liver Diseases and their Complications

Author(s): J.A. Ansari | Mateen Sayyed | Faizan Sayeed
Clinical and histological features of non-Alcoholic steatohepatitis in Iranian patients

Author(s): "Ebrahimi Daryani N | Mirmomen Sh | Bahrami H | Haghpanah B | Nayerhabibi A "
NASH - Diagnostik und Therapie: eine Übersicht

Author(s): Zauner C | Zauner A | Assi R | Brunner P | Grafl E | Hofstätter E | Kleinberger M | Lindner B | Putz C | Roszuzcky N | Sasko V | Sulyok I
Noninvasive predictors for liver fibrosis in patients with nonalcoholic steatohepatitis

Author(s): Hüseyin Saadettin Uslusoy | Selim Giray Nak | Macit Gülten
Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk

Author(s): Lucia Pacifico | Valerio Nobili | Caterina Anania | Paola Verdecchia | Claudio Chiesa
Probiotics in hepatology

Author(s): Jan Lata | Jana Jurankova | Marcela Kopacova | Petr Vitek
Adiponectin, a key adipokine in obesity related liver diseases

Author(s): Christa Buechler | Josef Wanninger | Markus Neumeier
The role of leptin and adiponectin in chronic liver diseases

Author(s): E. Tsochatzis, G.V. Papatheodoridis
Non-Alcoholic steatohepatitis and primary hepatic carcinoma

Author(s): E.V. Tsianos, D. Chirstodoulou
Affiliate Program      Why do you need a reservation system?